CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells. https://t.co/Yf75tdCM1Q
56 followers
1,000 followers
RT @sitcancer: #JITC Short Report: CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived sup…
440 followers
RT @sitcancer: #JITC Short Report: CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived sup…
19,289 followers
#JITC Short Report: CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells https://t.co/sCUGFQ9l3j https://t.co/x37MJyDKPK